Patients with Parkinson's Disease Patients Are Often Administered a Catechol-O-Methyltransferase
Multiple Choice
Patients with Parkinson's disease patients are often administered a catechol-O-methyltransferase (COMT) inhibitor because COMT
A) interacts poorly with other drugs frequently used to treat Parkinson's disease.
B) metabolizes a major portion of the administered l-DOPA before it reaches the brain.
C) prevents the conversion of tyrosine to DOPA.
D) builds up very quickly in the body and can lead to adverse reactions.
Correct Answer:
Verified
Correct Answer:
Verified
Q37: Write a coherent and informative paragraph incorporating
Q38: Increased levels of DA or NE in
Q39: The dopamine pathway most important for regulating
Q40: The drugs Ritalin and Adderall are used
Q41: Which drugs can bypass the requirement for
Q43: A(n) _ inhibitor of catecholamine vesicular uptake
Q44: Recent research indicates that supersensitivity to a
Q45: Compare and contrast the D<sub>1</sub> and D<sub>2</sub>
Q46: Which statement about norepinephrine (NE) is false?<br>A)
Q47: D<sub>1</sub> and D<sub>2</sub> dopamine receptor subtypes have